Skip to main content
Signal8

BAMFORD PASCAL

SEC insider (Form 3/4/5 filer). CIK 0002035474. Chief Clinical Officer at Akoya Biosciences, Inc. (AKYA). 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2025. Located in MARLBOROUGH, MA.

Companies BAMFORD PASCAL has filed insider reports for

  • Akoya Biosciences, Inc. (AKYA): Officer, Chief Clinical Officer
BAMFORD PASCAL profile photo

BAMFORD PASCAL

CIK: 0002035474

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)5 (71.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Akoya Biosciences, Inc. logo
AKYA

Akoya Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Direct
    9.5K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Direct
    196.3K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jun 1, 2025
    Tax Payment
    Direct
    670 shares at avg. $1.25$837.5
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Mar 1, 2025
    Tax Payment
    Direct
    1.3K shares at avg. $1.63$2K
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Mar 1, 2025
    Tax Payment
    Direct
    2.6K shares at avg. $1.63$4K
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Nov 19, 2024
    Award
    Direct
    87.5K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Aug 29, 2024
    Award
    Direct
    40K shares-

1-7 of 7